抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)
Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoco
The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.
监管决定及完整条件
- 状态
- Prohibited
- 法律地位
- Binding rule
- 监管摘要
- The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.
- 条件与限制
Prohibited in cosmetic product formulas. Verify the cited Chinese source identity and any later NMPA amendment before use.
物质身份
- 官方来源名称
- 抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)
- CAS
- 87-10-5; 67-96-9; 536-33-4; 67-45-8; 65277-42-1; 443-48-1; 67-20-9; 60-56-0; 1404-88-2
- EC
- Not supplied in this source row
- 身份映射
- Exact CAS: 65277-42-1
- 关联成分
- KETOCONAZOLE
关联的 CosIng 身份数据
名称和别名
CosIng 描述: Ketoconazole is the heterocyclic compound that conforms to the formula
欧盟清单限制备注: II/1528
已记录的化妆品功能: NOT REPORTED
功能页面:NOT REPORTED
查看完整的成分档案该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
European Union
7 条关联记录
打开支持记录Great Britain
7 条关联记录
打开支持记录Canada
6 条关联记录 · 1 条含特定条件
打开支持记录New Zealand
7 条关联记录
打开支持记录ASEAN
7 条关联记录
打开支持记录China
当前记录1 条关联记录 · 1 条含特定条件
打开支持记录South Korea
7 条关联记录 · 1 条含特定条件
打开支持记录Brazil
8 条关联记录 · 8 条含特定条件
打开支持记录India
7 条关联记录 · 7 条含特定条件
打开支持记录Saudi Arabia
7 条关联记录
打开支持记录
CAS 1404-88-2 的已核实化学信息
Tyrothricin
Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus. This complex is a mixture comprised of 60% tyrocidine cationic cyclic decapeptides (consisting largely of the six predominant tyrocidines, TrcA/A1, TrcB/B1, TrcC/C1, and other more minor contributors) and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary). Moreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years of therapeutic use the complex has provided. Nevertheless, as tyrothricin is both cytolytic and hemolytic, it does demonstrate systemic toxicity, although certain formulations that are safe for human use like throat lozenges do exist. — DrugBank
- IUPAC 名称
- 3-[(3R,6S,9S,12S,15S,17S,20S,22R,25S,28S)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan-17-yl]propanoic acid
- 分子式
- C65H85N11O13
- 分子量
- 1228.4 g/mol
- 精确质量
- 1227.63283181 Da
- 单同位素质量
- 1227.63283181 Da
- XLogP3
- 1.9
- 拓扑极性表面积
- 380.0 Ų
- 分子复杂度
- 2390.0
- 形式电荷
- 0
- 氢键供体
- 12
- 氢键受体
- 15
- 可旋转键
- 19
- 重原子
- 89
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEMBL:CHEMBL577736
高级结构统计
- 已定义的原子立体中心
- 10
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维构象异构体
- 0
机器可读的结构标识符
- SMILES
CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](C(=O)[C@@H](NC(=O)[C@@H](N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN)C(C)C)CC3=CC=C(C=C3)O)CCC(=O)O)CC(=O)N)CC4=CC=CC=C4)CC5=CC=CC=C5)CC6=CC=CC=C6- InChI
InChI=1S/C65H85N11O13/c1-38(2)32-49-60(84)74-52(36-42-20-12-7-13-21-42)65(89)76-31-15-23-53(76)63(87)73-51(34-41-18-10-6-11-19-41)61(85)70-47(33-40-16-8-5-9-17-40)57(81)48(37-54(67)78)71-59(83)46(28-29-55(79)80)68-50(35-43-24-26-44(77)27-25-43)62(86)75-56(39(3)4)64(88)69-45(22-14-30-66)58(82)72-49/h5-13,16-21,24-27,38-39,45-53,56,68,77H,14-15,22-23,28-37,66H2,1-4H3,(H2,67,78)(H,69,88)(H,70,85)(H,71,83)(H,72,82)(H,73,87)(H,74,84)(H,75,86)(H,79,80)/t45-,46-,47+,48-,49-,50-,51-,52+,53-,56-/m0/s1- InChIKey
NLJVXZFCYKWXLH-DXTIXLATSA-N
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 443-48-1 的已核实化学信息
Metronidazole
Metronidazole is a member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. It has a role as a radiosensitizing agent, an antiamoebic agent, an antimicrobial agent, an antiparasitic agent, a xenobiotic, an antibacterial drug, a prodrug, an antitrichomonal drug and an environmental contaminant. It is a primary alcohol, a member of imidazoles and a C-nitro compound. It is a conjugate base of a metronidazole(1+). — ChEBI
- IUPAC 名称
- 2-(2-methyl-5-nitroimidazol-1-yl)ethanol
- 分子式
- C6H9N3O3
- 分子量
- 171.15 g/mol
- 精确质量
- 171.06439116 Da
- 单同位素质量
- 171.06439116 Da
- XLogP3
- 0.0
- 拓扑极性表面积
- 83.9 Ų
- 分子复杂度
- 170.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 4
- 可旋转键
- 2
- 重原子
- 12
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 7
- 三维环
- 1
- 三维疏水基团
- 0
- 三维受体特征
- 3
- 三维供体特征
- 1
- 三维阴离子中心
- 1
- 三维阳离子中心
- 1
- 三维构象异构体
- 2
- 有效三维可旋转键
- 3.0
机器可读的结构标识符
- SMILES
CC1=NC=C(N1CCO)[N+](=O)[O-]- InChI
InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3- InChIKey
VAOCPAMSLUNLGC-UHFFFAOYSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 536-33-4 的已核实化学信息
Ethionamide
Ethionamide is a thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide. It has a role as an antitubercular agent, an antilipemic drug, a leprostatic drug, a fatty acid synthesis inhibitor and a prodrug. It is a member of pyridines and a thiocarboxamide. — ChEBI
- IUPAC 名称
- 2-ethylpyridine-4-carbothioamide
- 分子式
- C8H10N2S
- 分子量
- 166.25 g/mol
- 精确质量
- 166.05646950 Da
- 单同位素质量
- 166.05646950 Da
- XLogP3
- 1.1
- 拓扑极性表面积
- 71.0 Ų
- 分子复杂度
- 147.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 2
- 可旋转键
- 2
- 重原子
- 11
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:4885
- ChEMBL:CHEMBL1441
- EPA DTXSID:DTXSID0020577
- PubMed:33814510
- PubMed:32808185
- PubMed:26708503
- PubMed:26062974
- PubMed:25051504
- PubMed:23112434
- PubMed:23107633
- PubMed:23106273
- PubMed:23020577
- PubMed:23019444
- PubMed:22952439
- PubMed:22904807
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 4
- 三维环
- 1
- 三维疏水基团
- 1
- 三维受体特征
- 2
- 三维供体特征
- 0
- 三维阴离子中心
- 0
- 三维阳离子中心
- 0
- 三维构象异构体
- 10
- 有效三维可旋转键
- 2.0
机器可读的结构标识符
- SMILES
CCC1=NC=CC(=C1)C(=S)N- InChI
InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)- InChIKey
AEOCXXJPGCBFJA-UHFFFAOYSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 60-56-0 的已核实化学信息
Methimazole
Methimazole is a member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen. It has a role as an antithyroid drug. — ChEBI
- IUPAC 名称
- 3-methyl-1H-imidazole-2-thione
- 分子式
- C4H6N2S
- 分子量
- 114.17 g/mol
- 精确质量
- 114.02516937 Da
- 单同位素质量
- 114.02516937 Da
- XLogP3
- -0.3
- 拓扑极性表面积
- 47.4 Ų
- 分子复杂度
- 119.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 1
- 可旋转键
- 0
- 重原子
- 7
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:50673
- ChEMBL:CHEMBL1515
- EPA DTXSID:DTXSID4020820
- PubMed:41580965
- PubMed:38685447
- PubMed:34788025
- PubMed:34757178
- PubMed:33814510
- PubMed:32808185
- PubMed:32020584
- PubMed:31697382
- PubMed:31629072
- PubMed:31066087
- PubMed:30814441
- PubMed:30320502
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 3
- 三维环
- 1
- 三维疏水基团
- 0
- 三维受体特征
- 1
- 三维供体特征
- 1
- 三维阴离子中心
- 0
- 三维阳离子中心
- 0
- 三维构象异构体
- 1
- 有效三维可旋转键
- 0.0
机器可读的结构标识符
- SMILES
CN1C=CNC1=S- InChI
InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)- InChIKey
PMRYVIKBURPHAH-UHFFFAOYSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 65277-42-1 的已核实化学信息
Ketoconazole
(2S,4R)-ketoconazole is a cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2S,4R)-configuration. It is an enantiomer of a (2R,4S)-ketoconazole. — ChEBI
- IUPAC 名称
- 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
- 分子式
- C26H28Cl2N4O4
- 分子量
- 531.4 g/mol
- 精确质量
- 530.1487608 Da
- 单同位素质量
- 530.1487608 Da
- XLogP3
- 4.3
- 拓扑极性表面积
- 69.1 Ų
- 分子复杂度
- 735.0
- 形式电荷
- 0
- 氢键供体
- 0
- 氢键受体
- 6
- 可旋转键
- 7
- 重原子
- 36
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:47518
- ChEMBL:CHEMBL295698
- EPA DTXSID:DTXSID60161949
- PubMed:40976440
- PubMed:38795739
- PubMed:38734219
- PubMed:37788138
- PubMed:37077353
- PubMed:36893891
- PubMed:36653537
- PubMed:36621641
- PubMed:36374910
- PubMed:36332690
- PubMed:35478211
- PubMed:35358606
高级结构统计
- 已定义的原子立体中心
- 2
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 11
- 三维环
- 5
- 三维疏水基团
- 0
- 三维受体特征
- 4
- 三维供体特征
- 0
- 三维阴离子中心
- 0
- 三维阳离子中心
- 2
- 三维构象异构体
- 10
- 有效三维可旋转键
- 10.2
机器可读的结构标识符
- SMILES
CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl- InChI
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1- InChIKey
XMAYWYJOQHXEEK-ZEQKJWHPSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-20-9 的已核实化学信息
Nitrofurantoin
Nitrofurantoin is an imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA. It has a role as an antiinfective agent, an antibacterial drug and a hepatotoxic agent. It is an imidazolidine-2,4-dione, an organonitrogen heterocyclic antibiotic, an organooxygen heterocyclic antibiotic and a nitrofuran antibiotic. It is functionally related to a semicarbazide. — ChEBI
- IUPAC 名称
- 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
- 分子式
- C8H6N4O5
- 分子量
- 238.16 g/mol
- 精确质量
- 238.03381930 Da
- 单同位素质量
- 238.03381930 Da
- XLogP3
- -0.5
- 拓扑极性表面积
- 121.0 Ų
- 分子复杂度
- 390.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 6
- 可旋转键
- 2
- 重原子
- 17
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 1
- 未定义的键立体中心
- 0
- 三维药效团特征
- 10
- 三维环
- 2
- 三维疏水基团
- 0
- 三维受体特征
- 6
- 三维供体特征
- 1
- 三维阴离子中心
- 1
- 三维阳离子中心
- 0
- 三维构象异构体
- 10
- 有效三维可旋转键
- 3.6
机器可读的结构标识符
- SMILES
C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]- InChI
InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+- InChIKey
NXFQHRVNIOXGAQ-YCRREMRBSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-45-8 的已核实化学信息
Furazolidone
Furazolidone is a member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera. It has a role as an antiinfective agent, an antibacterial drug, an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antitrichomonal drug. It is a member of oxazolidines and a nitrofuran antibiotic. — ChEBI
- IUPAC 名称
- 3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
- 分子式
- C8H7N3O5
- 分子量
- 225.16 g/mol
- 精确质量
- 225.03857033 Da
- 单同位素质量
- 225.03857033 Da
- XLogP3
- -0.1
- 拓扑极性表面积
- 101.0 Ų
- 分子复杂度
- 326.0
- 形式电荷
- 0
- 氢键供体
- 0
- 氢键受体
- 6
- 可旋转键
- 2
- 重原子
- 16
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 1
- 未定义的键立体中心
- 0
- 三维药效团特征
- 8
- 三维环
- 2
- 三维疏水基团
- 0
- 三维受体特征
- 5
- 三维供体特征
- 0
- 三维阴离子中心
- 1
- 三维阳离子中心
- 0
- 三维构象异构体
- 6
- 有效三维可旋转键
- 3.8
机器可读的结构标识符
- SMILES
C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]- InChI
InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+- InChIKey
PLHJDBGFXBMTGZ-WEVVVXLNSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-96-9 的已核实化学信息
Dihydrotachysterol
Dihydrotachysterol is a hydroxy seco-steroid that is 9,10-secoergosta-5,7,22-triene substituted by a hydroxy group at position 3. A synthetic analogue of vitamin D that acts a bone density conservation agent. It has a role as a bone density conservation agent. It is a vitamin D, a seco-ergostane and a hydroxy seco-steroid. — ChEBI
- IUPAC 名称
- trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
- 分子式
- C28H46O
- 分子量
- 398.7 g/mol
- 精确质量
- 398.354866087 Da
- 单同位素质量
- 398.354866087 Da
- XLogP3
- 7.7
- 拓扑极性表面积
- 20.2 Ų
- 分子复杂度
- 639.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 1
- 可旋转键
- 5
- 重原子
- 29
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:4591
- ChEMBL:CHEMBL2356023
- EPA DTXSID:DTXSID5022938
- PubMed:15585789
- PubMed:10515239
- PubMed:6262039
- PubMed:4365509
- PubMed:3320562
- PubMed:198519
高级结构统计
- 已定义的原子立体中心
- 7
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 3
- 未定义的键立体中心
- 0
- 三维药效团特征
- 8
- 三维环
- 3
- 三维疏水基团
- 3
- 三维受体特征
- 1
- 三维供体特征
- 1
- 三维阴离子中心
- 0
- 三维阳离子中心
- 0
- 三维构象异构体
- 10
- 有效三维可旋转键
- 7.2
机器可读的结构标识符
- SMILES
C[C@H]\1CC[C@@H](C/C1=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C)O- InChI
InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1- InChIKey
ILYCWAKSDCYMBB-OPCMSESCSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 87-10-5 的已核实化学信息
3,4',5-Tribromosalicylanilide
Tribromosalicylanilide is a salicylanilide derivative with bromo- substituents at C-3 and C-5 of the salicylate moiety and at C-4 of the anilide moiety. It is functionally related to a salicylanilide. — ChEBI
- IUPAC 名称
- 3,5-dibromo-N-(4-bromophenyl)-2-hydroxybenzamide
- 分子式
- C13H8Br3NO2
- 分子量
- 449.92 g/mol
- 精确质量
- 448.80847 Da
- 单同位素质量
- 446.81052 Da
- XLogP3
- 5.0
- 拓扑极性表面积
- 49.3 Ų
- 分子复杂度
- 321.0
- 形式电荷
- 0
- 氢键供体
- 2
- 氢键受体
- 2
- 可旋转键
- 2
- 重原子
- 19
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:127105
- ChEMBL:CHEMBL24944
- EPA DTXSID:DTXSID4026181
- PubMed:33352258
- PubMed:21826158
- PubMed:20922970
- PubMed:20067776
- PubMed:19668425
- PubMed:18479921
- PubMed:17228788
- PubMed:12755728
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 8
- 三维环
- 2
- 三维疏水基团
- 3
- 三维受体特征
- 1
- 三维供体特征
- 2
- 三维阴离子中心
- 0
- 三维阳离子中心
- 0
- 三维构象异构体
- 5
- 有效三维可旋转键
- 3.0
机器可读的结构标识符
- SMILES
C1=CC(=CC=C1NC(=O)C2=C(C(=CC(=C2)Br)Br)O)Br- InChI
InChI=1S/C13H8Br3NO2/c14-7-1-3-9(4-2-7)17-13(19)10-5-8(15)6-11(16)12(10)18/h1-6,18H,(H,17,19)- InChIKey
KVSKGMLNBAPGKH-UHFFFAOYSA-N
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- China NMPA banned raw-material catalogues (2021)
- 来源参考
- NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 299
- 来源记录 ID
chemical-299- 来源版本
- NMPA Announcement No. 74 of 2021, effective 2021-05-26
- 来源语言
- Chinese with source English/Latin identity
- 翻译状态
- Official English translation · 英文译文
- 生效日期
- 2021-05-26
- 来源更新
- 2021-05-26
- 快照检查时间
- 2026-08-31 14:13 UTC
- 验证方法
- pdfplumber tables; exact 1,284 + 109 row counts and contiguous source numbering
- SHA-256
8848aa3e0c7ac5e74f56fc27927336c4fc2e5bc80137da087c2ca9ba2d2c075e
已登记的数据集备注
- 数据集覆盖范围
- All 1,284 banned raw materials and 109 banned plant/animal raw materials effective from 26 May 2021
- 权威性说明
- Binding NMPA catalogues replacing Tables 1 and 2 of the 2015 Technical Specification
本记录在市场数据集中的位置
China 市场背景
Complete prohibited catalogues plus official-source workflow
覆盖版本: NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
All 1,284 banned raw materials and 109 banned plant/animal raw materials, plus the official workflow for the dynamic existing-ingredient inventory, other technical restrictions and new ingredients.
核实清单
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
官方市场来源
- China NMPA IECIC dynamic inventoryOfficial NMPA inventory, not a blanket permission or safety decision
- China draft mandatory cosmetic safety standardConsultation draft — not current law and not a substitute for the effective NMPA catalogues
- China NMPA banned raw-material catalogues (2021)Binding NMPA catalogues replacing Tables 1 and 2 of the 2015 Technical Specification
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC未提供
- 单独的条件文本可用
- 生效日期可用
- 快照哈希与方法可用
本页回答的问题
稳定引用
抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2). NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 299. China. Source version NMPA Announcement No. 74 of 2021, effective 2021-05-26. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/cn/records/11988/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
China 的解读与局限
This official record identifies the substance as prohibited for cosmetic use in the stated market scope.
Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.
如何解读法律地位
The cited row forms part of a binding rule or legally incorporated list for this market.
本页证据
- 记录结果:Prohibited
- 法律地位:Binding rule
- 来源版本:NMPA Announcement No. 74 of 2021, effective 2021-05-26
- 生效日期:2021-05-26
它不能证明什么
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份